Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study

Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up

(2014) T. Waddell et al.   EJSO

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

(2014) Sung Hoon Noh et al.   LANCET ONCOLOGY

Adjuvant therapy for gastric cancer: Current and future directions

(2014) Marcus Foo   WORLD JOURNAL OF GASTROENTEROLOGY

Cost analysis of S1 and XELOX as adjuvant therapy for gastric cancer

(2013) Jianping He et al.   ANTI-CANCER DRUGS

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry

(2012) Atsushi Nashimoto et al.   Gastric Cancer

Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

(2012) Stephen R. Smalley et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Japanese classification of gastric carcinoma: 3rd English edition

(2011)   Gastric Cancer

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

(2011)   Gastric Cancer

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

(2011) Mitsuru Sasako et al.   JOURNAL OF CLINICAL ONCOLOGY

Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer

(2010) D. Takahari et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer

(2010) T. Doi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY